Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Significant Accounting Policies [Line Items] Significant Accounting Policies [Line Items] Significant accounting policies. Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security Document Fiscal Year Focus Document Fiscal Year Focus Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Right to exchange limited common stock to common stock, share Right To Exchange Each Share Of Limited Common Stock To Common Stock Right to exchange each share of limited common stock to common stock. Increase in ROU asset Increase (Decrease) in Operating Lease, Right-of-Use Asset Increase (Decrease) in Operating Lease, Right-of-Use Asset Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] Agreement with Gates Ventures, LLC Agreement With Gates Ventures Limited Liability Company [Member] Agreement with Gates Ventures, Limited Liability Company. Customer Customer [Axis] Segment Reporting [Abstract] Segment Reporting [Abstract] Common stock Common Stock, Value, Issued Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Over Time Transferred over Time [Member] Customer B Customer B [Member] Customer B. Restatement Determination Date Restatement Determination Date Contract assets Contract with Customer, Asset, after Allowance for Credit Loss Issuance of common stock upon vesting of RSUs and PRSUs (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Oncology, Neurology, and Immunology Product Oncology, Neurology, And Immunology Product [Member] Oncology, Neurology, And Immunology Product Amendment Flag Amendment Flag Proceeds from disposition and sale of equity investments, net Proceeds from Sale of Equity Method Investments Current liabilities: Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Principal payments on finance leases Finance Lease, Principal Payments Lease liabilities - operating leases Increase (Decrease) In Operating Lease Liabilities Increase decrease in operating lease liabilities. Number of neurology target remaining Contract With Customer, Number Of Neurology Target Remaining Contract With Customer, Number Of Neurology Target Remaining Number of programs under agreement Collaborative Agreement Number Of Programs Collaborative agreement number of programs. Timing of Transfer of Good or Service [Domain] Timing of Transfer of Good or Service [Domain] Related Party Transactions Related Party Transactions Disclosure [Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Limited common stock Limited Common Stock [Member] Limited common stock. Entity Address, State or Province Entity Address, State or Province Cash payments to purchase of shares Payments to Acquire Equity Securities, FV-NI Series C Preferred Stock Series C Preferred Stock [Member] Grant of common stock (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Revenue recognized with milestones Revenue Recognized For Milestone Payment Revenue recognized for milestone payment. PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Assets: Assets, Fair Value Disclosure [Abstract] Weighted average shares used to compute net income (loss) per share of common and limited common stockholders, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Tranche One Share-Based Payment Arrangement, Tranche One [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Fair Value By Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Novartis Pharma AG Novartis Pharma AG [Member] Novartis Pharma AG APAC EMEA [Member] Entity Address, City or Town Entity Address, City or Town Stock granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Equity investments Equity Method Investments, Fair Value Disclosure February 2023 Award February 2023 Award [Member] February 2023 Award Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Document And Entity Information [Line Items] Document Information [Line Items] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Number of units vested during period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Class of Stock [Axis] Class of Stock [Axis] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Level 2 Fair Value, Inputs, Level 2 [Member] Other income (expense): Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Revenue Benchmark Revenue Benchmark [Member] United States UNITED STATES Concentration Risk Type Concentration Risk Type [Axis] Gates Ventures, LLC Gates Ventures, LLC [Member] Gates Ventures, LLC Drug discovery contribution Drug Discovery Contribution [Member] Drug Discovery Contribution Net Income (Loss) per Share Attributable to Common and Limited Common Stockholders Earnings Per Share, Policy [Policy Text Block] Recently Issued Accounting Pronouncements and Recently Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Purchases of property and equipment in accounts payable Capital Expenditures Incurred but Not yet Paid Deferred revenue (includes related party amounts of $4,064 and $(3,736)) Deferred revenue Increase (Decrease) in Contract with Customer, Liability Summary of Financial Information with Respect to Reportable Segments Segment Reporting [Table Text Block] (Gain) loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Total future minimum lease payments Lessee, Operating And Finance Lease, Liability, To Be Paid Lessee, Operating And Finance Lease, Liability, To Be Paid Related Party Related and Nonrelated Parties [Axis] Number of votes for common share Number Of Votes For Common Share Number of votes for common share. Summary of Maturities of Operating Lease Liabilities Under Noncancelable Operating Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Supplemental disclosure of non-cash investing and financing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Collaboration and License Agreement Collaboration And License Agreement [Member] Collaboration and license agreement. Document Period End Date Document Period End Date Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Unrecognized tax benefits Unrecognized Tax Benefits Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Stockholders' Equity Equity [Text Block] Security Exchange Name Security Exchange Name Noncash investment accretion Investment Amortization Noncash Expense Investment amortization noncash expense. Purchases of marketable securities Payments to Acquire Marketable Securities Fair value of RSUs vested during the period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Lease liabilities - operating leases Operating Lease, Liability, Current Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Number of shares purchased (in shares) Number Of Shares Purchased Number Of Shares Purchased Net Income (Loss) per Share Attributable to Common and Limited Common Stockholders Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings Per Share [Abstract] Earnings Per Share [Abstract] Proceeds from maturity of marketable securities Proceeds from Sale and Maturity of Marketable Securities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Geographical Geographical [Domain] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] March 2025 Award March 2025 Award [Member] March 2025 Award Maximum percentage of stock options must be granted at exercise price of fair market value (less than) (in percent) Maximum Percentage Of Stock Options Must Be Granted At Exercise Price Of Fair Market Value Maximum percentage of stock options must be granted at exercise price of fair market value. Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Unrecognized compensation cost related to unvested stock options granted Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Company Selected Measure Name Company Selected Measure Name Sale of Stock Sale of Stock [Domain] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Award Date [Axis] Award Date [Axis] Revenue arrangements, contract term Revenue Arrangements, Contract Term Revenue Arrangements, Contract Term Other accrued liabilities Increase (Decrease) in Other Accrued Liabilities Related Party Transactions [Abstract] Related Party Transactions [Abstract] Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Weighted average shares used to compute net income (loss) per share of common and limited common stockholders, diluted (in shares) Weighted average shares used to compute net income (loss) per share of common and limited common stockholders, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Disaggregation Of Revenue [Line Items] Disaggregation of Revenue [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Tranche Four Share-Based Compensation Award Tranche Four [Member] Share-based compensation award tranche four. Underlying Security Market Price Change Underlying Security Market Price Change, Percent Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Purchase price (in USD per share) American Depository Shares Purchased, Price Per Share American Depository Shares Purchased, Price Per Share Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Award vesting rights (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage March 2024 Award March 2024 Award [Member] March 2024 Award Award Date [Domain] Award Date [Domain] Gross profit Total segment gross profit Gross Profit Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] On-premise software On Premise Software [Member] On premise software. Cost of revenues: Segment cost of revenues Cost of Revenue [Abstract] Award Timing Predetermined Award Timing Predetermined [Flag] Restricted cash (includes related party amounts of $63 and $72, respectively) Restricted cash Restricted Cash, Current Intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] BMGFT Gates Foundation Trust [Member] Bill and Melinda gates foundation trust. Effect of the exercise of common stock options and vested RSUs on weighted average common and limited common shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements All Executive Categories All Executive Categories [Member] Increase in lease liability Increase (Decrease) in Operating Lease Liability Software Agreement Software Agreement [Member] Software Agreement Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share The ATM The ATM [Member] The ATM Total deferred revenue Revenue, Remaining Performance Obligation, Deferred Revenue Revenue, Remaining Performance Obligation, Deferred Revenue Vesting [Domain] Vesting [Domain] Plan Name [Domain] Plan Name [Domain] Antidilutive Securities Antidilutive Securities [Axis] Sales and marketing Sales and marketing Selling and Marketing Expense Right of use assets - operating leases Operating Lease, Right-of-Use Asset Concentration Risk Type Concentration Risk Type [Domain] Unbilled and other receivables Increase Decrease In Unbilled And Other Receivables Increase decrease in unbilled and other receivables. Schedule of Basic and Diluted Net (Loss) Income Per Share Attributable to Common and Limited Stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Common Stock Unallocated Common Stocks [Member] Unallocated common stock. Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Segment Reporting Segment Reporting [Text Block] Equity Investments Investment in Debt and Equity Securities and Other Trading Assets [Text Block] Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Net increase in cash and cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Schedule of Revenue Recognized from the Sources of Software Products and Services Revenue Disaggregation of Revenue [Table Text Block] Income Statement Location Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents and restricted cash Cash and Cash Equivalents, Fair Value Disclosure Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Axis] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Drug discovery Drug Discovery [Member] Drug discovery. Shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction EMEA APAC [Member] APAC Exercise Price Award Exercise Price Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Issuance of common stock upon vesting of RSUs and PRSUs Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Segment Reporting [Line Items] Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments Segments [Domain] Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Deferred revenue, short-term: Deferred Revenue, Current [Abstract] Performance Based Restricted Stock Units Performance Based Restricted Stock Units [Member] Performance Based Restricted Stock Units Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity investments Equity Method Investments Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Consideration received on transaction Sale of Stock, Consideration Received on Transaction Adoption Date Trading Arrangement Adoption Date Counterparty Name Counterparty Name [Domain] Total stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Total other income Nonoperating Income (Expense) Denominator: Weighted Average Number Of Shares Outstanding Basic And Diluted [Abstract] Weighted average number of shares outstanding basic and diluted. Number of specified biological targets Contract With Customer, Number Of Specified Biological Targets Contract With Customer, Number Of Specified Biological Targets Software products and services Software Products And Services [Member] Software products and services. Marketable securities Equity Securities, FV-NI, Current Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Accounting Policies [Abstract] Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Risk-free interest rate (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Insider Trading Policies and Procedures [Line Items] Allowance for doubtful accounts receivable Accounts Receivable, Allowance for Credit Loss, Current Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Lessee, operating lease, number of contract Lessee, Operating Lease, Number of Contracts Lessee, Operating Lease, Number of Contracts Segment gross profit: Gross Profit [Abstract] Revenues From External Customers And Long Lived Assets [Line Items] Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Total shares subject to outstanding common stock options and unvested RSUs and PRSUs (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Restricted Stock Units Restricted Stock Units (RSUs) [Member] Schedule of Potentially Dilutive Securities not Included in Diluted Per Share Calculations Anti-dilutive Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key Additional paid-in capital Additional Paid in Capital, Common Stock All Adjustments to Compensation All Adjustments to Compensation [Member] Software contribution revenue recognition Software Contribution Revenue Recognized Software contribution revenue recognized. Equity [Abstract] Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Income Taxes Income Tax, Policy [Policy Text Block] Net cash (used in) provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Contract with customers, payment terms Contract With Customers Payment Terms Contract with customers, payment terms. Accounts Receivable Accounts Receivable [Member] Percentage of revenue expected to be recognized Revenue, Remaining Performance Obligation, Percentage Income Statement [Abstract] Income Statement [Abstract] Stockholders' equity: Equity, Attributable to Parent [Abstract] Change in fair value of equity investments Increase (Decrease) in Equity Securities, FV-NI Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Investment, Name Investment, Name [Axis] Operating expenses: Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Summary of Weighted Average Valuation Assumptions Used for Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Fair value of shares vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value City Area Code City Area Code Accumulated other comprehensive income (loss) AOCI Attributable to Parent [Member] Document And Entity Information [Table] Document Information [Table] All Individuals All Individuals [Member] Subsequent Events Subsequent Events [Text Block] Schedule of Revenues by Geographic Area Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue [Table Text Block] Name Forgone Recovery, Individual Name Unrecognized compensation cost expected to be recognized over a weighted average period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Statement [Line Items] Statement [Line Items] Eligible to vest (in shares) Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Eligible To Vest, Number Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Eligible To Vest, Number Receivable, after allowance for credit loss, current Contract with Customer, Receivable, after Allowance for Credit Loss, Current Total assets Assets Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Weighted average fair value of options granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Summary of Classification of Stock Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Non-marketable equity security Equity Securities without Readily Determinable Fair Value, Amount Stock-Based Compensation Share-Based Payment Arrangement [Text Block] PEO PEO [Member] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Total stock-based compensation Share-Based Payment Arrangement, Expense Conversion ratio Preferred Stock, Convertible, Conversion Ratio Marketable securities Marketable Securities, Current Other liabilities, long-term Other Liabilities, Noncurrent Goodwill Goodwill Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Issuances of common stock upon stock option exercises (in shares) Options, exercises in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Weighted average fair value of restricted stock units granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Deferred revenue, revenue recognized Contract with Customer, Liability, Revenue Recognized Change in fair value of equity investments Mark-to-market gain (loss) on equity investments Equity Securities, FV-NI, Gain (Loss) Accumulated deficit Retained Earnings [Member] Lease liabilities - operating leases, long-term Operating Lease, Liability, Noncurrent Total operating expenses Operating Expenses Eligible Performance Based Restricted Stock Units Eligible Performance Based Restricted Stock Units [Member] Eligible Performance Based Restricted Stock Units Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Drug Discovery Drug Discovery Segment [Member] Drug Discovery Segment. Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Unrealized loss on marketable securities Unrealized loss on marketable securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Robert Abel [Member] Robert Abel Deferred income Deferred Income Net income (loss) per share of common and limited common stockholders, diluted (in USD per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accrued payroll, taxes, and benefits Increase (Decrease) in Employee Related Liabilities BMS Bristol Myers Squibb [Member] Bristol-Myers Squibb. Contract Assets Contract Assets [Member] Contract Assets Research and development Research and development Research and Development Expense Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] 2028 Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Two Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Two Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Total revenues Total segment revenues Revenue from Contract with Customer, Excluding Assessed Tax Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Segment revenues Segment Reporting, Revenue [Abstract] Financial Instruments [Domain] Financial Instruments [Domain] Unbilled and other receivables, net of allowance for unbilled receivables of $140 and $140 Unbilled And Other Receivables Current Unbilled and other receivables current. Issuances of common stock upon stock option exercises Stock Issued During Period, Value, Stock Options Exercised 2020 Plan Twenty Twenty Stock Plan [Member] Twenty twenty stock plan. Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Revenue Recognition Revenue from Contract with Customer [Text Block] Prepaid expenses Prepaid Expense, Current Proceeds from issuances of common stock upon stock option exercises Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised 2027 Lessee, Operating And Finance Lease, Liability, To Be Paid, Year One Lessee, Operating And Finance Lease, Liability, To Be Paid, Year One Present value of future minimum lease payments Operating And Finance Lease, Liability Operating And Finance Lease, Liability Hosted software Hosted Software [Member] Hosted software. Allowance for unbilled receivable Allowance For Unbilled Receivables Current Allowance for unbilled receivables current. Achievement percent Share-Based Compensation Arrangement By Share-Based Payment Award, Achievement Percent Share-Based Compensation Arrangement by Share-Based Payment Award, Achievement Percent Schedule Of Segment Reporting Information By Segment [Table] Segment Reporting [Table] Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Software contribution revenue recognition amount Software Contribution Revenue Recognition Amount Software contribution revenue recognition amount. Schedule Of Related Party Transactions By Related Party [Table] Related Party Transaction [Table] Schedule Of Equity Method Investments [Table] Equity Method Investment [Table] Sale of Stock Sale of Stock [Axis] Summary of Operating Leases Lease, Cost [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Loss from operations Operating Income (Loss) Voting Common Stock Voting Common Stock [Member] Voting common stock. Unsatisfied performance obligation Total remaining performance obligations Revenue, Remaining Performance Obligation, Amount Current Fiscal Year End Date Current Fiscal Year End Date Collaboration milestone payment Collaboration Agreement, Milestone Payment Collaboration Agreement, Milestone Payment Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Less: current portion of lease payments Operating And Finance Lease, Liability, Current Operating And Finance Lease, Liability, Current Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Number of performance obligations Number Of Performance Obligations Number Of Performance Obligations Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Description of Business Business Description and Basis of Presentation [Text Block] Equity Components [Axis] Equity Components [Axis] Number of preferred shares purchased (in shares) Number Of Preferred Shares Purchased Number of preferred shares purchased. Accounts receivable, net (includes related party amounts of $(4,900) and zero) Accounts receivable, net Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Related Party Related Party [Member] Class Of Stock [Line Items] Class of Stock [Line Items] Cash paid for income taxes Income Tax Paid, after Refund Received ADR ADR [Member] Disaggregation Of Revenue [Table] Disaggregation of Revenue [Table] Entity Interactive Data Current Entity Interactive Data Current Cash paid for leases Operating And Finance Lease, Payments Operating And Finance Lease, Payments Purchases of property and equipment in accrued liabilities Noncash or Part Noncash Acquisition, Fixed Assets Acquired Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Termination Date Trading Arrangement Termination Date Total backlog Revenue, Remaining Performance Obligation, Backlog Revenue, Remaining Performance Obligation, Backlog Subsequent Events [Abstract] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Stock split, conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Options granted, contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Other assets Other Assets, Noncurrent Document Type Document Type Structure Therapeutics Structure Therapeutics [Member] Structure therapeutics. July 2024 Agreement with Bill & Melinda Gates Foundation July 2024 Agreement With Bill & Melinda Gates Foundation [Member] July 2024 Agreement With Gates Ventures Limited Liability Company Fair Value as of Grant Date Award Grant Date Fair Value Significant Accounting Policies Significant Accounting Policies [Text Block] Contribution Contribution Contribution [Member] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Software contribution Drug Discovery Services [Member] Drug discovery member. Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Deferred revenue, long-term Contract with Customer, Liability, Noncurrent Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Unallocated (expense) income: Unallocated [Abstract] Unallocated. Valuation assumptions Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Decrease (increase) in assets: Increase (Decrease) in Operating Assets [Abstract] Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies (Note 5) Commitments and Contingencies Total revenues Total software revenue Total contribution revenue Revenues Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Changes in market value of investments, net of tax: OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Discovery and development milestones to be received Revenue, Remaining Performance Obligation, Variable Consideration, Research, Development and Regulatory Milestones, Amount Revenue, Remaining Performance Obligation, Variable Consideration, Research, Development and Regulatory Milestones, Amount (Decrease) increase in liabilities: Increase (Decrease) in Operating Liabilities [Abstract] Award vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Counterparty Name Counterparty Name [Axis] Point in Time Transferred at Point in Time [Member] Acquisition of right of use assets in exchange for lease liabilities - operating leases Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations Noncash Or part noncash acquisitions of right of use assets in exchange for lease obligations. Liabilities and Stockholders' Equity: Liabilities and Equity [Abstract] Commercial milestones to be received Revenue, Remaining Performance Obligation, Variable Consideration, Commercial Milestones, Amount Revenue, Remaining Performance Obligation, Variable Consideration, Commercial Milestones, Amount Schedule of Assets and Liabilities Measured at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] All Award Types Award Type [Domain] Ajax Therapeutics, Inc Ajax Therapeutics Inc [Member] Ajax Therapeutics, Inc. Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Fair Value Measurements Fair Value Disclosures [Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Supplemental disclosure of cash flow and noncash information Supplemental Cash Flow Information [Abstract] Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Cash, cash equivalents, restricted cash, and marketable securities Cash, Cash Equivalents, Restricted Cash, And Marketable Securities, Current Cash, Cash Equivalents, Restricted Cash, And Marketable Securities, Current Expected to be recognized over a weighted average period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] PEO Name PEO Name Geographical Geographical [Axis] Deferred revenue Contract with Customer, Liability Concentrations Concentration Risk, Credit Risk, Policy [Policy Text Block] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Equity Investments Equity Method Investments [Policy Text Block] Cash and cash equivalents and restricted cash, beginning of period Cash and cash equivalents and restricted cash, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Accounts payable Increase (Decrease) in Accounts Payable Other accrued liabilities Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Percentage of voting securities Percentage Of Voting Securities Percentage of voting securities. Nimbus Therapeutics, LLC Nimbus Therapeutics L L C [Member] Nimbus Therapeutics LLC. Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Lease costs Lease, Cost Closing price of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Related party transactions amount Related Party Transaction, Amounts of Transaction Investment, Name Investment, Name [Domain] Customer Customer [Domain] Net income (loss) per share of common and limited common stockholders, basic (in USD per share) Earnings Per Share, Basic Deferred revenue Deferred Revenue Deferred revenue (includes related party amounts of $4,148 and $84, respectively) Deferred revenue, current Contract with Customer, Liability, Current Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Accrued payroll, taxes, and benefits Accrued Payroll Taxes, Current Total cost of revenues Total segment cost of revenues Cost of Revenue Award Type Award Type [Axis] Thereafter Lessee, Operating And Finance Lease, Liability, To Be Paid, After Year Four Lessee operating lease liability payments due after year four. Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable, net of allowance for doubtful accounts of $265 and $440 (includes related party amounts of $5,000 and $100, respectively) Net receivables Accounts Receivable, after Allowance for Credit Loss, Current Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Less: imputed interest Lessee, Operating And Finance Lease, Liability, Undiscounted Excess Amount Lessee, Operating And Finance Lease, Liability, Undiscounted Excess Amount Common stock Common Stock [Member] Marketable securities Debt Securities, Available-for-Sale Expected volatility (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Lease term Finance And Operating Lease, Weighted Average Remaining Lease Term Finance And Operating Lease, Weighted Average Remaining Lease Term Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Cover [Abstract] Reclassifications of Prior Year Presentation Reclassification, Comparability Adjustment [Policy Text Block] Rest of World Non-US [Member] Expected dividend yield (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Series B Preferred Stock Series B Preferred Stock [Member] Significant Accounting Policies [Table] Significant Accounting Policies [Table] Significant accounting policies. Concentration risk, percentage Concentration Risk, Percentage Concentration Risk Benchmark Concentration Risk Benchmark [Axis] Equity Awards Adjustments Equity Awards Adjustments [Member] Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Number of shares available to issue in transaction Sale of Stock, Remaining Value Of Shares Available For Issuance Sale of Stock, Remaining Value Of Shares Available For Issuance Total liabilities and stockholders' equity Liabilities and Equity Research, Collaboration and License Agreement Research, Collaboration and License Agreement [Member] Research, Collaboration and License Agreement Employee Stock Option Share-Based Payment Arrangement, Option [Member] Schedule Of Revenues From External Customers And Long Lived Assets [Table] Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table] Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Segments Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Software contribution Software Contribution [Member] Software contribution. Related Party Related and Nonrelated Parties [Domain] Tabular List, Table Tabular List [Table Text Block] Vesting [Axis] Vesting [Axis] Software Software Segment [Member] Software Segment. Other income Other Nonoperating Income (Expense) Name Awards Close in Time to MNPI Disclosures, Individual Name Number of shares per award Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Award Conversion Upon Achievement, Number Of Shares Per Award Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Award Conversion Upon Achievement, Number Of Shares Per Award Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Number of units forfeited during period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period General and administrative (includes related party expense of $165, $109, $330 and $218) General and administrative General and administrative General and Administrative Expense Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, $0.01 par value. Authorized 10,000,000 shares; zero shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Preferred Stock, Value, Issued Adjustment to Compensation: Adjustment to Compensation [Axis] Software maintenance Maintenance [Member] Proceeds from equity investment Proceeds From Equity Securities, FV-NI Proceeds From Equity Securities, FV-NI Professional services Professional Services [Member] Professional services. Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total Assets, Fair Value Disclosure Milestone payment yet to be achieved Milestone Payment Yet To Be Achieved Milestone payment yet to be achieved. Name Measure Name Deferred revenue, long-term: Deferred Revenue, Noncurrent [Abstract] Income Taxes Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Remainder of 2026 Lessee, Operating And Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Lessee, Operating And Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Proceeds from disposal of shares Proceeds from Sale of Equity Securities, FV-NI Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional paid-in capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Director Director [Member] Software contribution Revenue Not from Contract with Customer Columbia University and Richard Friesner Columbia University and Richard Friesner [Member] Columbia University and Richard Friesner Name Trading Arrangement, Individual Name Unrecognized compensation cost related to vested stock options granted Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Cash and cash equivalents Cash and Cash Equivalent Customer C Customer C [Member] Customer C Concentration Risk Benchmark Concentration Risk Benchmark [Domain] Company Selected Measure Amount Company Selected Measure Amount Basis of Presentation and Use of Estimates Basis Of Presentation And Use Of Estimates Policy [Policy Text Block] Basis of presentation and use of estimates. Investments, Debt and Equity Securities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Timing of revenue recognition Timing Of Revenue Recognition Percentage Timing of revenue recognition, percentage. Lease liabilities, long-term Operating And Finance Lease, Liability, Noncurrent Operating And Finance Lease, Liability, Noncurrent Entity Address, Address Line Two Entity Address, Address Line Two Schedule Of Stock By Class [Table] Stock, Class of Stock [Table] Net income (loss) Net loss Consolidated net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Current assets: Assets, Current [Abstract] Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Income tax expense Income tax expense Income Tax Expense (Benefit) 2029 Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Three Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Three Customer Concentration Risk Customer Concentration Risk [Member] Award Timing Method Award Timing Method [Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Total milestones to be received from initial programs Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Reduction in the carrying amount of right of use assets - operating leases Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets, Operating Increase (decrease) in reduction in the carrying amount of right of use assets. Tranche Three Share-Based Payment Arrangement, Tranche Three [Member] Net income (loss) Net income (loss) Net income (loss) attributable to Schrödinger common and limited common stockholders Net Income (Loss) Attributable to Parent Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] March 2026 Award March 2026 Award [Member] March 2026 Award Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from issuances of common stock upon stock option exercises Proceeds from Stock Options Exercised 2030 Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Four Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Four Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule of Timing of Revenue Recognition Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Proceeds from equity stake in Ajax Proceeds From Equity Securities, Equity Stake In Company Proceeds From Equity Securities, Equity Stake In Company Schedule of Contract Balances Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] 2010 Plan Two Thousand Ten Stock Plan [Member] Two thousand ten stock plan. Customer A Customer A [Member] Customer A. RSUs and PRSUs Share-Based Payment Arrangement [Member] Revenues: Revenues [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]